SCHEMBL1273617

SCHEMBL1273617

CCC(C[C@@H](N)C(=O)OC(=O)CC[C@@H](N)C(=O)O)C(=O)OC(=O)CC[C@@H](N)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A1 P43005 7/20 0.50
▸ SLC1A2 P43004 6/20 0.50
▸ SLC1A3 P43003 5/20 0.50
▸ GRIK1 P39086 5/20 0.44
▸ GRIK2 Q13002 5/20 0.44
▸ GCLC P48506 2/20 0.42
▸ GRM8 O00222 1/20 0.42
▸ GRM6 O15303 1/20 0.42
▸ GRIN2D O15399 1/20 0.42
▸ GRIN3B O60391 1/20 0.42
▸ GSR P00390 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ GRM5 P41594 1/20 0.42
▸ GRIA1 P42261 1/20 0.42
▸ GRIA2 P42262 1/20 0.42
▸ GRIA3 P42263 1/20 0.42
▸ GRIA4 P48058 1/20 0.42
▸ GRIN1 Q05586 1/20 0.42
▸ GRIN2A Q12879 1/20 0.42
▸ GRIK3 Q13003 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839696 0.85 SLC1A1 (0.48) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL3512082 0.83 SLC7A5 (0.55) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL3510710 0.81 SLC1A1 (0.47) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL7717181 0.80 SLC1A1 (0.54) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL2994699 0.80 SLC1A1 (0.54) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL6267781 0.80 SLC1A1 (0.54) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL931954 0.80 SLC1A1 (0.54) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL3430330 0.80 SLC1A1 (0.54) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL3918242 0.80 SLC1A1 (0.54) SLC1A1SLC1A2SLC1A3GRIK1GRIK2
SCHEMBL1410127 0.79 SLC1A1 (0.48) SLC1A1SLC1A2SLC1A3GRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3112468-A1 IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF Genentech, Inc. (US) 2017-01-04 — — EP disclosed
US-20120128627-A1 IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF CHEN JIAN (US) 2012-05-24 — — US disclosed
US-8075888-B2 Methods of treatment using antibodies to IL-17 homologous polypeptides GENENTECH, INC. (US) 2011-12-13 — — US disclosed
EP-2333069-A2 Therapeutic uses of IL-17 homologous polypeptides Genentech, Inc. (US) 2011-06-15 — — EP disclosed
US-20110038868-A1 IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF CHEN JIAN 2011-02-17 — — US disclosed
EP-1076703-B2 THERAPEUTIC USES OF IL-17 HOMOLOGOUS POLYPEPTIDES GENENTECH INC (US) 2010-12-15 — — EP disclosed
US-7749500-B2 Antibodies to IL-17 polypeptides and therapeutic uses thereof GENENTECH, INC. (US) 2010-07-06 — — US disclosed
US-20090022725-A1 IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF CHEN JIAN 2009-01-22 — — US disclosed
EP-1865061-A2 IL-17 homologous polypeptides and therapeutic uses thereof Genentech, Inc. (US) 2007-12-12 — — EP disclosed
EP-1076703-B1 THERAPEUTIC USES OF IL-17 HOMOLOGOUS POLYPEPTIDES GENENTECH INC (US) 2007-06-27 — — EP disclosed
US-20070134238-A1 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases GENENTECH, INC. (US) 2007-06-14 — — US disclosed
US-7217412-B2 IL-17C related mammalian cytokine polypeptides GENENTECH, INC. (US) 2007-05-15 — — US disclosed
US-7115398-B2 IL-17 homologous polypeptides and therapeutic uses thereof GENENTCH, INC. (US) 2006-10-03 — — US disclosed
US-20060205038-A1 IL-I7 homologous polypeptides and therapeutic uses thereof GENENTECH, INC 2006-09-14 — — US disclosed
US-20020106743-A1 IL-17 homologous polypeptides and therapeutic uses thereof GENENTECH, INC. 2002-08-08 — — US disclosed
US-20020052027-A1 IL-17 homologous polypeptides and therapeutic uses thereof GENENTECH, INC. 2002-05-02 — — US disclosed
EP-1076703-A2 IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF Genentech, Inc. (US) 2001-02-21 — — EP disclosed
WO-1999060127-A9 IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF GENENTECH INC (US) 2000-03-30 — — WO disclosed
WO-1999060127-A2 IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF GENENTECH, INC. (US) 1999-11-25 — — WO disclosed
Send feedback